Edwin Spaans

Edwin has over 25 years of experience in industrial (and academic) R&D. Previously, Edwin held positions with increasing responsibility at former Organon (now MSD, the Netherlands), the Dutch Poisons Control Center, Actelion Pharmaceuticals in Switzerland and Kinesis-Pharma in the Netherlands providing over 20 years of leadership in delivering early clinical development projects. Under his accountability he advanced over 50 compounds successfully into the clinic and through Proof of Concept phase. Recent positions include a.o. CMO/CDO for Khondrion BV, Program leader for Oncurious, and AM-Pharma.Edwin holds a PharmD since ’97 (Utrecht University) and holds registrations as a Clinical Pharmacologist (2003) and as a specialist in Pharmaceutical Medicine (2011). He is an invited lecturer in Drug Development at Utrecht University and Erasmus University Rotterdam and several commercial drug development courses. Next to his position, Edwin is involved in pediatric drug development in public-private partnerships.